Longview News-Journal

SkylineDx Presents Landmark Study on Merlin CP-GEP beyond SLNB prediction: Transforming Melanoma Risk Assessment

Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death. Validates Merlin CP-GEP's prognostic power: Identifying tumors ...
Business Wire

CORRECTING and REPLACING Merlin Kicks Off KC-135 Test Flight Campaign with SNC to Progress Autonomous Capabilities for the United States Air Force

Real-time flight data is critical to progressing the design, integration, and eventual flight demonstrations of the Merlin Pilot, in addition to informing the planned Next Generation Air-Refueling ...
Medindia

New Data from SkylineDx Demonstrates Merlin CP-GEP Test's Superior Melanoma Risk Stratification

ROTTERDAM, Netherlands and SAN DIEGO, Calif., Dec. 18, 2025 /PRNewswire/ -- SkylineDx today announced the release of new data from two complementary, peer-reviewed publications that reinforce the ...
PR Newswire

SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma

First and only prospective blinded data confirm the Merlin CP-GEP (Clinico pathological-Gene Expression Profiling) Test accurately stratifies melanoma patients by sentinel node metastasis risk, ...
PR Newswire

New Data from SkylineDx Demonstrates Merlin CP-GEP Test's Superior Melanoma Risk Stratification

New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior ...